Health

Semaglutide may combat Alzheimer’s by reducing brain inflammation:Study

HQ Team March 21, 2025: A study from China adds to mounting evidence that semaglutide—a medication widely used for type 2 diabetes (Ozempic).

Read More
Health Pharma Research

Abnormal protein accumulation in patient’s eyes linked to Alzheimer’s

HQ Team March 4, 2025: Tau proteins in brain neurons can form neurofibrillary tangles, which are a hallmark of Alzheimer’s disease, and these.

Read More
Health Medical Pharma

Medtronic Plc’s neurostimulator for Parkinson’s gets USFDA approval

Ireland’s Medtronic Plc’s deep brain stimulation device for patients with Parkinson’s disease has been approved by the US Food and Drug Administration, according.

Read More
Drugs Health Research

Cambridge researchers making brain implants to treat Parkinson’s

Researchers at Cambridge are developing implants that could help repair damaged brain cells and treat diseases like Parkinson’s.

Read More
Drugs Pharma Research

New insights on GLP-1 drugs: Benefits and risks unveiled

HQ Team January 21, 2024: The popular diabetes drugs, glucagon-like peptide-1 (GLP-1) receptor agonists such as Ozempic, have gained immense popularity for their.

Read More
Drugs Medical Pharma

Biogen Inc., to buy 62m outstanding shares of Sage for $441.7 million

Biogen Inc., plans to buy all outstanding shares totalling 61.17 million of Sage Therapeutics Inc., for $7.22 a share, representing a premium of.

Read More
Health Medical

Sleeping pills show promise in reducing Alzheimer’s proteins

HQ Team December 28, 2024: Research has shown a potential connection between the progression of Alzheimer’s disease in people who take sleeping pills..

Read More
Health Medical

Taxi and ambulance drivers may have lower Alzheimer’s risk, study finds

HQ Team December 18, 2024: Taxi and ambulance drivers may have a lower risk of dying from Alzheimer’s disease compared to many other.

Read More
Drugs Pharma

Breakthrough in halting dementia progression found by biotech company

HQ Team December 12, 2024: Filamon Limited, an Australian biotech company, has announced a significant advancement in dementia treatment with its new drug,.

Read More
Health Medical

Belly fat during middle age linked to Alzheimer’s disease risk

Bharti Jayshankar December 3, 2024: If you are overweight and have accumulated body fat around your belly in your middle years then you.

Read More